24R ,25( OH ) 2 D 3 regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane‐associated receptor complexes in ER + and ER− cells
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70141 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Cydney D Dennis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Estrogen Receptor alpha, Carcinogenesis, Receptors, Estrogen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, 2022 Vitamin D Workshop, Austin, Texas, Joan and Morgan Massey Foundation, Richmond, VA.
Abstract (Originalsprache)
This study examined the effects of 24R,25‐dihydroxyvitamin D 3 (24R,25(OH) 2 D 3 ) in estrogen‐responsive laryngeal cancer tumorigenesis in vivo, the mechanisms involved, and whether the ability of the tumor cells to produce 24R,25(OH) 2 D 3 locally is estrogen‐dependent. Estrogen receptor alpha‐66 positive (ER+) UM‐SCC‐12 cells and ER− UM‐SCC‐11A cells responded differently to 24R,25(OH) 2 D 3 in vivo; 24R,25(OH) 2 D 3 enhanced tumorigenesis in ER+ tumors but inhibited tumorigenesis in ER− tumors. Treatment with 17β‐estradiol (E 2 ) for 24 h reduced levels of CYP24A1 protein but increased 24R,25(OH) 2 D 3 production in ER+ cells; treatment with E 2 for 9 min reduced CYP24A1 at 24 h and reduced 24R,25(OH) 2 D 3 production in ER− cells. These findings suggest the involvement of E 2 receptor(s) in addition to ERα66. To investigate if 24R,25(OH) 2 D 3 can act locally, ER+ and ER− cells were treated with 24R,25(OH) 2 D 3 after inhibiting putative 24R,25(OH) 2 D 3 receptors, and the cells were assessed for effects on DNA synthesis (proliferation) and p53 production (apoptosis). Specific inhibitors were used to assess downstream secondary messenger signaling pathways and requirements for palmitoylation and caveolae in both cell lines. The results show that 24R,25(OH) 2 D 3 binds to a complex of receptors, including TLCD3B2, VDR, and protein disulfide‐isomerase A3 (PDIA3) in ER+ UM‐SCC‐12 cells. The mechanism requires palmitoylation, and PLD, PI3K, and LPAR are involved. The anti‐tumorigenic effects of 24R,25(OH) 2 D 3 in ER− UM‐SCC‐11A cells involve a membrane‐receptor complex consisting of VDR, PDIA3, and ROR2 within caveolae to activate a yet‐to‐be‐elucidated downstream signaling cascade. This work demonstrates a driving mechanism for the therapeutic agent 24R,25(OH) 2 D 3 that may be used for laryngeal cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Computer Science, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Surgery, Division of Otolaryngology - Head and Neck Surgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.
- Bioanalytical Core Laboratory, Central Virginia Drug Abuse Research Center, Virginia Commonwealth University, Richmond, Virginia, USA.
- Department of Periodontics, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Barbara D Boyan
Förderung
- NCI NIH HHS
- 2022 Vitamin D Workshop, Austin, Texas
- Joan and Morgan Massey Foundation, Richmond, VA
Zitieren
APA
Dennis, C. D., Cohen, D. J., Debnath, K., Schwartz, N., Lodato, B. P., Dillon, J. T., Batool, T., Halquist, M. S., Ghosh, P., Schwartz, Z., & Boyan, B. D. (2026). 24R ,25( OH ) 2 D 3 regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane‐associated receptor complexes in ER + and ER− cells. International Journal of Cancer. https://doi.org/10.1002/ijc.70141
Vancouver
Dennis CD, Cohen DJ, Debnath K, Schwartz N, Lodato BP, Dillon JT, et al. 24R ,25( OH ) 2 D 3 regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane‐associated receptor complexes in ER + and ER− cells. International Journal of Cancer. 2026. doi:10.1002/ijc.70141
BibTeX
@article{Dennis2026,
author = {Dennis, Cydney D and Cohen, D Joshua and Debnath, Kusal and Schwartz, Nofrat and Lodato, Brock P and Dillon, Jonathan T and Batool, Tillat and Halquist, Matthew S and Ghosh, Preetam and Schwartz, Zvi and Boyan, Barbara D},
title = {24R ,25( OH ) 2 D 3 regulates tumorigenesis in estrogen sensitive laryngeal cancer cells via membrane‐associated receptor complexes in ER + and ER− cells},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70141}
}
EUVIMED